We are live on ! Find out more
CTV.WS

Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share

Delisted

CTV.WS was delisted on the 12th of February, 2025.

16 hedge funds and large institutions have $109K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more capital invested

Capital invested by funds: $77.7K → $109K (+$31.1K)

0% more funds holding

Funds holding: 1616 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
16
Holders Change
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
1
Calls
$180K
Puts
Net Calls
+$180K
Net Calls Change
-$68K

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$1.36K

Top Sellers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
-$56

CTV.WS Hedge Fund Activity: Q2 2024 in Review

16 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q2 2024, worth a combined $109K — up 40% from $77.7K a quarter earlier.

Fund positioning in CTV.WS was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $1.36K. The largest seller was First Manhattan, exiting entirely with an estimated $56 sold.

  • 16 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $109K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q2 2024, up 40% quarter-over-quarter.
  • 1 fund opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q2 2024 and 1 closed out, a net change of 0 holders.
  • The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q2 2024 was Cantor Fitzgerald, an estimated $1.36K added.
  • The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q2 2024 was First Manhattan, an estimated $56 sold.

Based on aggregated 13F filings for Q2 2024.